![](/img/cover-not-exists.png)
SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients
Mei, Zhu, Shao, Yang W., Lin, Peinan, Cai, Xiaomin, Wang, Biao, Ding, Yan, Ma, Xiangyuan, Wu, Xue, Xia, Yewei, Zhu, Dongqin, Shu, Yongqian, Fu, Zan, Gu, YanhongVolume:
18
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-018-4298-5
Date:
December, 2018
File:
PDF, 796 KB
english, 2018